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Abstract
 
Interferon (IFN)-
 
 
 
 plays an important role in the innate immune response against intracellular
bacterial pathogens. It is commonly thought that natural killer cells are the primary source of
this cytokine that is involved in activating antibacterial effects in infected cells and polarizing
CD4
 
 
 
 T cells toward the Th1 subset. However, here we show that both effector and memory
CD8
 
 
 
 T cells have the potential to secrete IFN-
 
 
 
 in response to interleukin (IL)-12 and IL-18
in the absence of cognate antigen. We demonstrate that memory CD8
 
 
 
 T cells specific for the
ovalbumin protein secrete IFN-
 
 
 
 rapidly after infection with wild-type 
 
Listeria monocytogenes
 
(LM). Furthermore, small numbers of ovalbumin-specific, memory CD8
 
 
 
 T cells can reduce
spleen and liver bacterial counts in IFN-
 
 
 
–deficient mice 3 d after LM infection. Up-regulation
of the receptors for IL-12 and IL-18 provides a mechanism for the ability of memory CD8
 
 
 
 T
cells to respond in this antigen nonspecific manner. Thus, CD8
 
 
 
 T cells play an important role
in the innate immune response against intracellular pathogens by rapidly secreting IFN-
 
 
 
 in
response to IL-12 and IL-18.
Key words: innate immunity • T lymphocytes • cytokines • 
 
Listeria monocytogenes
 
 • IFN-
 
 
 
Introduction
 
The immune response against pathogenic microorganisms
involves two components: a rapid, antigen nonspecific,
innate response and a delayed, acquired response specific
for the antigens displayed by the invading microbe. Studies
using the intracellular bacterium 
 
Listeria monocytogenes
 
 (LM)
have been useful in establishing the kinetics and mecha-
nisms of both the innate and adaptive immune responses
against intracellular pathogens in general. The innate immune
response to LM is a complex network involving multiple
cell types, cytokines, and bactericidal effector mechanisms
(1, 2). The adaptive immune response to LM is T cell–
mediated and required for complete resolution of the bacte-
rium as evidenced by studies using T cell–deficient mice (3).
In the experimental murine model of LM infection, cir-
culating monocytes and resident macrophages, such as
Kupffer cells, play an important role in innate immunity by
ingesting and destroying LM (1). The generation of reactive
nitrogen and oxygen intermediates by infected macro-
phages and neutrophils results in direct killing of LM (4–6),
although mechanisms independent of these intermediates
also can play a role in host resistance (7–9). In support of the
role of phagocytic cells and their effector functions, depletion
of macrophages (10) or neutrophils (11) results in impaired
innate resistance against LM.
Multiple cells of the immune system play a role in the
innate response by reducing the bacterial load directly and
secreting cytokines such as IL-1, IL-6, TNF-
 
 
 
, IFN-
 
 
 
,
 
 
 
and
others. IL-1 is produced by LM-infected macrophages,
and blockade of the IL-1 signaling pathway leads to an in-
creased LM burden in mice (12). The mechanism involved in
IL-1–mediated protection from LM infection is probably
recruitment and activation of both neutrophils and macro-
phages (13). Likewise, IL-6 is rapidly secreted after LM in-
fection (14). Removing this cytokine by depletion or gene
targeting results in increased susceptibility to LM due to in-
efficient neutrophil recruitment (15, 16). A recent report
has shown increased LM susceptibility in lymphotoxin 
 
 
 
receptor–deficient mice (17). Although TNF-
 
 
 
 and IFN-
 
 
 
production  were not affected in these mice, nitric oxide
production by macrophages was impaired.
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Studies using mice deficient in either TNF-
 
 
 
 or its re-
ceptor identify this cytokine as being important in innate
immunity to LM (18, 19). TNF-
 
 
 
 functions not only to
induce IFN-
 
 
 
 production (20) but also to directly activate
macrophages independent of IFN-
 
 
 
 (21). IL-12 and IL-18,
produced mainly by activated macrophages, are both im-
portant mediators in the immune response against LM, and
their primary function is to induce IFN-
 
 
 
 secretion from
responding immune cells (20–23). However, an IFN-
 
 
 
–
independent role in controlling LM has also been proposed
for IL-18 (24).
IFN-
 
 
 
 is produced by multiple cell types including NK
cells (25), NK-T cells (26), macrophages (27), B cells (28),
dendritic cells (29), and 
 
  
 
 T cells (30). Evidence that IFN-
 
 
 
is critically important in the innate immune response
comes from experiments using mice deficient in either the
cytokine or its receptor. These animals rapidly succumb
when infected with low doses of LM (31, 32). SCID mice,
which lack T and B lymphocytes, show increased suscepti-
bility to LM when they are depleted of either IFN-
 
 
 
 or IL-
12 (21, 33). Providing IFN-
 
 
 
 to IL-12–depleted SCID
mice can reverse this effect (21). One mechanism for the
increased susceptibility of animals lacking the IFN-
 
 
 
 recep-
tor, or presumably the cytokine itself, is impaired macro-
phage activity (34).
It is generally thought that NK cells play an important
role in the control of LM infection due to secretion of
IFN-
 
 
 
 induced by IL-12 and IL-18 (25). In contrast, one
study found that depleting NK cells led to decreased LM
burdens in B6 mice (35). However, the IFN-
 
 
 
–secreting
activity of NK cells or any other cell type has never been
directly tested for its ability to provide innate protection
against LM infection. One cell type that can contribute to
IFN-
 
 
 
 secretion during the innate immune response is
CD8
 
 
 
 T cells. We and others have shown that CD44
 
hi
 
CD8
 
 
 
 T cells respond to cytokines by secreting IFN-
 
 
 
rapidly after infection with intracellular bacteria (36, 37).
Since this population of CD8
 
 
 
 T cells is as numerous as
NK cells in normal mice, we directly tested their activity in
vivo. This report demonstrates that memory CD8
 
 
 
 T cells
provide protection against LM infection in IFN-
 
 
 
–defi-
cient animals in an antigen nonspecific manner.
 
Materials and Methods
 
Mice.
 
C57BL/6J (B6), C57BL/6.PL-Thy1
 
a
 
/Cy (B6.Thy1.1),
B6.129S7-
 
Ifng
 
tm1Ts
 
 (IFN-
 
 
 
 
 
/
 
 
 
), and OT-I TCR transgenic mice
were bred and maintained at the University of Texas Southwest-
ern Medical Center animal facility under the approval of the In-
stitutional Animal Care and Use Committee.
 
Bacteria and Viruses.
 
For infection of cell lines and mice, log
phase cultures of LM 10403 serotype 1 or LM-expressing full-
length ovalbumin protein (LM/OVA), provided by Dr. Hao
Shen (University of Pennsylvania School of Medicine, Philadel-
phia, PA) (38), were washed twice and diluted in PBS to the de-
sired concentration. LM or LM/OVA were injected in the lateral
tail vein at the indicated dosage.
Vesicular stomatitis virus (VSV)–expressing full-length ovalbu-
min protein (VSV/OVA) was provided by Dr. Leo Lefrancois
 
(University of Connecticut Health Center, Farmington, CT)
(39). Vaccinia virus (VV)–expressing full-length ovalbumin pro-
tein (VV/OVA) was provided by Dr. Jack Bennink (National In-
stitutes of Health, Bethesda, MD) (40). VSV/OVA and VV/
OVA were injected in the lateral tail vein at a dosage of 2 
 
 
 
 10
 
6
 
PFU for a primary response.
 
Cell Lines, Cell Culture, and Reagents.
 
The J774 macrophage
line (H-2
 
d
 
) and the J774 macrophage line stably transfected with
H-2K
 
b
 
 (J774:K
 
b
 
) were grown in complete DMEM (Life Tech-
nologies) supplemented with 10% FCS (Atlanta Biologicals). For
overnight in vitro experiments, the culture of mouse splenocytes
was performed in complete RPMI (Life Technologies) supple-
mented with 10% FCS and 10 ng/ml recombinant human IL-2
(provided by Dr. Michael Bennett, UTSW). In experiments de-
signed to test the direct ex vivo activity of T cells, splenocytes
were cultured for 3 h in complete RPMI supplemented with
10% FCS (without added cytokines or antigens). Recombinant
murine IL-12 (5 ng/ml final concentration) and IL-18 (10 ng/ml
final concentration) were from Peprotech Inc. Blocking antibod-
ies against murine IL-12 and IL-18 (1 
 
 
 
g/ml final concentration)
were purchased from Peprotech Inc. and Medical and Biological
Laboratories Co., Ltd., respectively. Carboxyfluorescein diace-
tate, succinimidyl ester (CFSE) labeling of splenocytes was per-
formed at a final concentration of 1 
 
 
 
M and was obtained from
Molecular Probes. The OVA-derived peptide SIINFEKL was
synthesized by the UTSW peptide synthesis facility.
 
Antibodies and Cell Staining.
 
For cell staining experiments,
the following antibodies from BD Biosciences were used: anti-
CD8
 
 
 
 (53–6.7), anti-CD44 (IM7), anti-CD90.2 (Thy1.2) (53–
2.1), anti-CD94 (18d3), and anti–IFN-
 
 
 
 (XMG1.2). Secondary
streptavidin-conjugated reagents were used to reveal biotinylated
primary or secondary antibodies. Intracellular staining, data ac-
quisition, and data analysis were performed as described previ-
ously (36). Staining for the presence of the IL-18R
 
 
 
 subunit was
accomplished using an anti–IL-18R
 
 
 
 antibody (R&D Systems)
followed by biotinylated anti–goat IgG (Jackson Immuno-
Research Laboratories), which was then revealed with streptavi-
din-conjugated PE. Identification of endogenous OVA-specific T
cells was performed by first incubating the splenocytes with a
blocking CD8
 
 
 
 antibody (CT-CD8
 
 
 
) from Caltag Laboratories.
After washing, the splenocytes were incubated at 4
 
 
 
C for 1 h
with CD8
 
 
 
 FITC and a K
 
b
 
-SIINFEKL tetramer coupled to PE
that was purchased from the Protein Chemistry Core Laboratory
at Baylor College of Medicine.
 
In Vitro Stimulations.
 
Red blood cell–depleted splenocytes
were cultured in 24-well plates at a concentration of 3 
 
 
 
 10
 
6
 
/
well. J774 or J774:K
 
b
 
 macrophages cultured in antibiotic-free me-
dia were infected at a multiplicity of infection of 5:1 for 1 h. The
macrophages were then washed three times with PBS and cul-
tured for 3 h in complete DMEM supplemented with 10% FCS
and gentamycin (100 
 
 
 
g/ml). The infected macrophages were
then harvested and plated at 3 
 
 
 
 10
 
5
 
/well with the splenocytes.
 
T Cell Transfers and In Vivo Stimulations.
 
Splenocytes from
OT-I TCR transgenic mice were passed over nylon wool columns
to enrich for T cells. 
 
 
 
3 
 
 
 
 10
 
6
 
 cells were then injected i.v. into
the lateral tail vein of B6.Thy1.1 recipient mice, rested for 1–3 d,
and challenged with the indicated pathogen as described above.
For the experiments analyzing OT-I T cells that were transferred
and not challenged, 10
 
7
 
 OT-I T cells were transferred into
B6.Thy1.1 hosts, and the mice were killed 1–3 d later for analysis.
 
Harvest of Peripheral Organs.
 
Mice were perfused before har-
vesting the organs according to a published protocol (41). Briefly,
mice were perfused with PBS containing 75 U/ml heparinT
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(Sigma-Aldrich). Lung tissue was minced and incubated with con-
stant stirring for 30 min at 37
 
 
 
C in HBSS containing 1.3 mM
EDTA (Sigma-Aldrich). The lung tissue was next treated with
150 U/ml collagenase (Sigma-Aldrich) in RPMI containing 5%
FCS for 1 h at 37
 
 
 
C. The resulting suspension was pelleted, resus-
pended in 44% Percoll (Amersham Biosciences), layered on 67.5%
Percoll, and centrifuged at 600 
 
g
 
 at 4
 
 
 
C for 15 min. Liver tissue
was homogenized, pelleted, resuspended in 35% Percoll contain-
ing 200 U/ml heparin, layered on 67.5% Percoll, and centrifuged
at 600 
 
g
 
 at 4
 
 
 
C for 15 min. Lung and liver lymphocytes at the gra-
dient interface were harvested and washed twice before use.
 
Real-time RT-PCR.
 
For the naive OT-I T cell population
used for real-time RT-PCR, splenocytes from naive OT-I mice
were purified on a nylon wool column to enrich for T cells and
then stained for CD8, V
 
 
 
2, and CD44. After washing, the sple-
nocyte population was sorted on the basis of CD8
 
 
 
, V
 
 
 
2
 
 
 
, and
CD44
 
lo
 
 using a MoFlo™ high speed sorter (Cytomation, Inc.).
The effector OT-I T cell population was obtained from
B6.Thy1.1 mice that were transferred with OT-I T cells and
then primed with LM/OVA. 7 d postinfection, the mice were
killed and the splenocytes were purified on a nylon wool column.
The resulting cells were stained for CD8 and Thy1.2 and sorted
for expression of these molecules. For the memory OT-I T cell
population, the same protocol was used as for the effector popu-
lation, except the mice were killed at 
 
 
 
4 wk postinfection. For
each of the sorted OT-I T cell populations, the purity of the cells
was 
 
 
 
95% as determined by flow cytometry after sorting.
RNA was purified from the sorted naive, effector, and mem-
ory OT-I T cell populations using QIAGEN RNeasy columns.
The protocol provided by the manufacturer was followed with
the addition of the on column DNA digestion using the RNase-
free DNase set from QIAGEN in order to remove any residual,
contaminating DNA. cDNA was then synthesized from the
RNA using the oligo-dT method and TaqMan™ reverse tran-
scription reagents from Applied Biosystems.
Real-time RT-PCR was performed on each of the three
cDNA populations to amplify GAPDH (as a control to normalize
for the quantity of cDNA), IL-12R
 
 
 
1, IL-12R
 
 
 
2, IL-18R
 
 
 
, and
IL-18R
 
 
 
. The primers used are listed from 5
 
 
 
 to 3
 
 
 
: GAPDH
sense, TGCACCACCAACTGCTTAG and GAPDH antisense,
GGATGCAGGGATGATGTTC; IL-12R
 
 
 
1 sense, GGCAA-
CATGACATCCATGCA and IL-12R
 
 
 
1 antisense, GTGTGT-
CACCATCTTGGCAGGATC; IL-12R
 
 
 
2 sense, CACTAT-
CAGGTGACGTTACA and IL-12R
 
 
 
2 antisense, TGCAG-
AAGCGCCTTTTGAGTTGGT; IL-18R
 
 
 
 sense, GTGCA-
CAGGAATGAAACAGC and IL-18R
 
 
 
 antisense, ATTTAAG-
GTCCAATTGCGACGA; and IL-18R
 
 
 
 sense, GGAGTGG-
GAAATGTCAGTAT and IL-18R
 
 
 
 antisense, CCGTGCC-
GAGAAGGATGTAT. An Applied Biosystems GeneAmp 5700
thermocycler was used in conjunction with the SYBR Green™
PCR Master Mix, also from Applied Biosystems. Each sample
was run in triplicate, and the data were analyzed using the 2
 
-
 
  
 
C
T
method (42) in order to determine the relative gene expression of
each of the IL-12 and IL-18 receptors.
Online Supplemental Material. Fig. S1 shows the ability of ef-
fector P14 TCR transgenic T cells generated in vivo to respond
in vitro to either a combination of IL-12 and IL-18 or their cog-
nate peptide.  After overnight culture of splenocytes containing
effector P14 T cells with the stimuli shown, the T cells secrete
IFN- .  This indicates that in addition to OT-I T cells, transgenic
CD8+ T cells with another specificity are responsive to IL-12 and
IL-18. Fig. S2 depicts the response of memory OT-I T cells gen-
erated in vivo to both LPS and Escherichia coli.  After culturing
Figure 1. Effector OT-I T cells secrete IFN-  in response to TCR
stimulation or a combination of IL-12 and IL-18 in vitro. 3   106 nylon
wool-purified OT-I splenocytes were transferred into B6.Thy1.1 mice
that were then infected with  2,000 LM/OVA (A), 2   106 PFU VV/
OVA (B), or 2   106 PFU VSV/OVA (C). 7 d after infection, the mice
were killed and splenocytes were stained to identify the OT-I T cells
and their activation/memory status. After gating on the CD8 ,
Thy1.2  population of OT-I T cells, the histograms indicate the per-
centage of cells positive for CD44 or CD94. Bulk splenocytes from the
LM/OVA (D), VV/OVA (E), or VSV/OVA (F) effector mice were in-
cubated overnight with the indicated culture conditions. GolgiPlug™
was added for the final 4 h of culture, and the cells were subsequently
harvested and stained for expression of CD8, Thy1.2, and intracellular
IFN- . The data are the average of two mice and are representative of
at least two independent experiments.T
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Figure 2. Memory OT-I T cells secrete IFN- 
in response to TCR stimulation or a combination
of IL-12 and IL-18 in vitro. 3   106 nylon wool-
purified OT-I splenocytes were transferred into
B6.Thy1.1 mice that were then infected with
 2,000 LM/OVA (A), 2   106 PFU VV/OVA
(B), or 2   106 PFU VSV/OVA (C). The mice
were then allowed to rest for  4 wk in order to
generate stable memory populations of OT-I T cells.
The mice were killed, and splenocytes were stained
to identify the OT-I T cells and their activation/
memory status. After gating on the CD8 ,
Thy1.2  population of OT-I T cells, the histo-
grams indicate the percentage of cells positive for
CD44 or CD94. Bulk splenocytes from the LM/
OVA (D), VV/OVA (E), or VSV/OVA (F) memory
mice were incubated overnight with the indicated
culture conditions. GolgiPlug™ was added for the
final 4 h of culture, and the cells were subsequently
harvested and stained for expression of CD8,
Thy1.2, and intracellular IFN- . The results shown
are the average of two mice and are representative
of at least two independent experiments. (G) OT-I
T cells that were transferred into B6.Thy1.1 mice
and not challenged were compared with similar
mice that were challenged with LM/OVA and
then rested for  4 wk. After overnight stimulation
with 10 nM SIINFEKL or a combination of IL-12
and IL-18, the cells were stained for CD8, Thy1.2,
and intracellular IFN- . The results from two mice
per group were averaged, and the experiment was
performed three times with similar results.
splenocytes containing memory OT-I T cells in vitro for 3 h in
the presence of GolgiPlug and the indicated stimuli, the OT-I T
cells secrete IFN- .  This result indicates that memory T cells have
the ability to secrete IFN-  in response to pathogens other than
LM. Fig. S3 compares the ability of sorted naive or memory OT-I
T cells to provide protection from LM infection in IFN-  / 
mice.  The memory OT-I T cells provide protection from a LM
infection as shown by the lowered LM colony counts in both the
spleen and liver.  The naive OT-I T cells do not provide pro-
tection from LM in either the spleen or the liver when they
are transferred into IFN-  /  mice. Figs. S1–S3 are available at
http://www.jem.org/cgi/content/full/jem.20031051/DC1.
Results
Responses of Effector CD8  T Cells to IL-12 and IL-18.
We demonstrated previously that a population of CD8 
T cells isolated from naive mice had the ability to respond
to LM-infected macrophages by secreting IFN-  (36). To
further investigate the potential of CD8  T cells to respond
in vivo to LM, we used an adoptive transfer protocol
where T cell–enriched splenocytes isolated from OT-I
TCR transgenic mice were transferred into B6.Thy1.1
congenic hosts. The mice were then challenged with a
strain of LM expressing the ovalbumin protein (LM/OVA)
to induce the activation of the OT-I T cells. 7 d after in-
fection, the CD8 , Thy1.2  population identifies the
transferred OT-I T cells, which express both V 2 and V 5
and also stain positive using a Kb-SIINFEKL tetramer (Fig.
1 A and unpublished data). The OT-I population of T cells
express the CD44 and CD94 molecules indicative of an ac-
tivated phenotype (Fig. 1 A), and splenocytes from these
mice are cytolytic against targets pulsed with the SIIN-
FEKL peptide (unpublished data). When splenocytes from
these OT-I–transferred, LM/OVA-primed mice were cul-
tured overnight with SIINFEKL or a combination of IL-12
and IL-18, intracellular IFN-  is detected in the majority
of the CD8 , Thy1.2  T cells (Fig. 1 D). In addition, stim-
ulation of the CD8 , Thy1.2  T cells to secrete IFN- 
with LM/OVA-infected J774:Kb macrophages could not
be blocked by antibodies against IL-12 and IL-18. In con-
trast, IFN-  secretion induced by LM/OVA-infected J774,
LM-infected J774, or LM-infected J774:Kb was blocked by
antibodies against IL-12 and IL-18.
To examine the effect of priming OT-I T cells with
other pathogens, we infected B6.Thy1.1 mice that had
been transferred with T cell–enriched OT-I splenocytesT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
Berg et al. 1587
with VV-expressing ovalbumin (VV/OVA) or VSV-
expressing ovalbumin (VSV/OVA). 7 d after infection, we
analyzed the cell surface phenotype of the CD8 , Thy1.2 
T cells to confirm that they had responded to antigen (Fig.
1, B and C). After overnight stimulation, the OT-I T cells
primed with either VV/OVA or VSV/OVA are able to re-
spond to IL-12 and IL-18 by secreting IFN-  (Fig. 1, E
and F). These effector T cells respond to LM-infected J774:
Kb by secreting IFN-  even though the cognate antigen
(OVA) is not provided. Antibodies against IL-12 and IL-18
block the IFN-  secretion induced by LM-infected J774:
Kb but not LM/OVA-infected J774:Kb. Similar responsive-
ness to IL-12 and IL-18 was observed using P14 TCR
transgenic CD8  T cells specific for lymphocytic chorio-
meningitis virus–derived glycoprotein 33–41 as an effector
population generated in vivo (Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20031051/DC1).
Responses of Memory CD8  T Cells to IL-12 and IL-18.
To further our understanding of the ability of CD8  T
cells to respond to IL-12 and IL-18, we used the same OT-
I transfer protocol as above but allowed the mice to rest for
 4 wk before analysis. During this time period, the OT-I
T cells respond to the antigen and then return to a resting
but memory state. B6.Thy1.1 mice transferred with OT-I
T cells that were challenged with LM/OVA (Fig. 2 A),
VV/OVA (Fig. 2 B), or VSV/OVA (Fig. 2 C) were ana-
lyzed for expression of memory and activation markers.
The expression of CD44 and CD94 on each of the trans-
ferred populations indicates that the OT-I T cells have a
memory phenotype. In addition, none of the memory
OT-I T cell populations expressed the activation markers
CD25 or CD69 (not depicted). After overnight culture of
splenocytes obtained from these animals, the OT-I T cells
responded equally well to IL-12 and IL-18 or the cognate
peptide in terms of their IFN-  response. Importantly, re-
gardless of the OVA-expressing pathogen used to generate
memory OT-I T cells, LM-infected J774:Kb stimulators in-
duced IFN-  secretion, and this effect was blocked by anti-
bodies against IL-12 and IL-18 (Fig. 2, D–F).
Our previous work has shown that a very small percent-
age of OT-I T cells stimulated directly ex vivo from an
OT-I mouse was able to secrete IFN-  (36). To analyze a
naive population of transferred CD8  T cells, T cell–
enriched OT-I splenocytes were injected into B6.Thy1.1
hosts, and their potential to secrete IFN-  without chal-
lenging the mice in vivo was determined. Indeed, a small
percentage of the transferred OT-I T cells was able to se-
crete IFN-  in response to either IL-12 and IL-18 or SI-
INFEKL (Fig. 2 G). The IFN- –secreting OT-I T cells
altered their cell surface phenotype compared with non-
transferred OT-I T cells with respect to CD44, CD94, and
other memory markers (unpublished data). These changes
may explain why some transferred OT-I T cells are slightly
more responsive to IL-12 and IL-18 compared with the
nontransferred population of OT-I T cells. However, the
nonprimed, transferred OT-I T cell population contained a
much lower percentage of IL-12– and IL-18–responsive T
cells compared with a memory population of OT-I T cells.
Furthermore, when we transferred OT-I T cells into
B6.Thy1.1 hosts and then attempted to prime with WT
LM there was no proliferation of the OT-I T cells as mea-
sured by CFSE labeling experiments (unpublished data).
Together, these data indicate that only effector and mem-
ory CD8  T cells have the capacity to secrete IFN-  in re-
sponse to IL-12 and IL-18 and that this response is not me-
diated through the TCR.
To analyze a population of antigen-specific, non-TCR
transgenic CD8  T cells, we injected B6 mice with LM/
OVA and identified endogenous OVA-specific CD8  T
cells using Kb-SIINFEKL tetramers (Fig. 3, A and B). Once
again, both effector (7 d postinfection) and memory ( 4
wk postinfection) OVA-specific CD8  T cells secreted
IFN-  when stimulated overnight with a combination of
IL-12 and IL-18 or their cognate peptide (Fig. 3, C and D).
This result, along with our previous work using bulk popu-
lations of CD8  T cells, (36) suggests that multiple popula-
tions of effector and memory CD8  T cells respond to IL-
12 and IL-18 by secreting IFN- .
Localization of Memory CD8  T Cells in Peripheral Organs
and Their Ability To Respond To IL-12 and IL-18. Previ-
ous reports indicate that memory T cells preferentially relo-
cate in peripheral organs (41, 43). When we compared the
localization of naive (transferred, unprimed) OT-I T cells
and memory (transferred, LM/OVA-primed) OT-I T cells,
we found that the memory OT-I T cells preferentially re-
located to nonlymphoid organs, whereas the naive OT-I T
Figure 3. Endogenous effector and memory OVA-specific T cells secrete
IFN-  in response to TCR stimulation or a combination of IL-12 and
IL-18 in vitro. (A and C) B6 mice were primed with LM/OVA and
killed 7 d later. Bulk splenocytes from these mice were incubated over-
night with the indicated culture conditions. GolgiPlug™ was added for
the final 4 h of culture, and the cells were stained with the Kb-SIINFEKL
tetramer and for CD8 and intracellular IFN- . (B and D) B6 mice were
primed with LM/OVA and killed  4 wk later. Splenocytes were cultured
and stained as in A and C. For each dot plot, one overnight culture with
IL-12 and IL-18 is shown out of six representative mice. The results in C
and D are the average of three mice for each group and were repeated
with similar results.T
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cells did not (Fig. 4, A and B). Importantly, when we re-
stimulated lymphocytes isolated from LNs, spleen, liver,
and lung we found that memory OT-I T cells were able to
respond to both SIINFEKL or a combination of IL-12 and
IL-18 by secreting IFN-  (Fig. 4 C). When this experi-
ment was repeated, we used SIINFEKL-pulsed J774:Kb as
stimulators to compensate for the low numbers of cells iso-
lated from the lung, and this increased the percentage of
IFN- –secreting OT-I T cells to  75% (unpublished
data). These results indicate that not only do memory
CD8  T cells preferentially reside in peripheral organs but
also that these T cells are capable of mounting an early,
rapid response against a pathogen-induced infection.
Rapid In Vivo Production of IFN-  from Memory CD8  T
Cells in Response To WT LM. To test whether or not
memory OT-I T cells respond to a WT LM infection in
vivo, we rechallenged OT-I–transferred, VSV/OVA-
primed memory mice for 16 h with differing doses of WT
LM. The splenocytes were then cultured for 3 h in media
with GolgiPlug™ and subsequently analyzed for IFN- 
production. Indeed, memory OT-I T cells responded to
WT LM in a dose-dependent fashion by secreting IFN- 
(Fig. 5). The probable reason for the requirement of high
doses of WT LM to induce a substantial percentage of the
OT-I T cells to secrete IFN-  is that the assay was per-
formed after only 16 h of infection. In other experiments,
 50% of the memory OT-I T cells were able to secrete
IFN-  3 d postinfection with the sublethal dose of  104
WT LM (unpublished data). OT-I–transferred, VSV/
OVA-primed memory mice were also injected with IL-12
and IL-18. Once again,  50% of the OT-I T cells stained
positive for intracellular IFN-  (unpublished data). These
results suggest that the combined actions of IL-12 and IL-
18 are responsible for inducing rapid IFN-  secretion in
memory CD8  T cells responding to WT LM. To expand
these findings to another organism, we infected memory
OT-I mice with E. coli and killed the mice 3 h later.  40%
of the memory OT-I T cells isolated from the E. coli–in-
fected mice secreted IFN-  (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20031051/DC1). To-
gether, these results indicate that memory CD8  T cells
have the ability to respond to multiple pathogens in an an-
tigen-independent fashion.
Up-regulation of IL-12 and IL-18 Receptors in Effector and
Memory CD8  T Cells. To establish a mechanism for the
increased IFN-  responsiveness of effector and memory
OT-I T cells to a combination of IL-12 and IL-18 com-
pared with their naive counterparts, we performed real-
time RT-PCR on sorted populations of naive, effector,
and memory OT-I T cells. Levels of IL-12R 2, IL-18R ,
and IL-18R  were all up-regulated in the effector and
memory OT-I T cell populations (Fig. 6 A). To confirm
these findings at the protein level, we analyzed naive, effec-
tor, and memory populations of OT-I T cells for expres-
sion of the IL-18R  subunit. Although in each population
of OT-I T cells the IL-18R  subunit is expressed, the ef-
fector and memory populations express approximately a
fivefold higher level than the naive population (Fig. 6,
B–D). The flow cytometry data, which supports the RT-
PCR data for the IL-18R  subunit, suggests that the anti-
bodies used for sorting to obtain the pure populations of
Figure 4. Memory OT-I T cells preferentially relocate to peripheral
organs and respond to IL-12 and IL-18 by secreting IFN- . (A) 107 nylon
wool-purified OT-I splenocytes were transferred into B6.Thy1.1 hosts.
(B and C) 3   106 nylon wool-purified OT-I T cells were transferred
into B6.Thy1.1 hosts, challenged with  2,000 LM/OVA, and then
rested for  4 wk. Graphs representing the percentage of Thy1.2  (OT-I)
cells out of the total CD8  population within the indicated organs for the
naive OT-I T cells (A) and the memory OT-I T cells (B) are shown. (C)
After overnight stimulation with either 10 nM SIINFEKL or a combination
of IL-12 and IL-18, the cells isolated from the indicated organs were
incubated for 4 h with GolgiPlug™ and then stained for CD8, Thy1.2,
and intracellular IFN- . Three mice were averaged per group, and the
data are representative of three independent experiments.
Figure 5. Memory OT-I T cells primed with VSV/OVA respond to
an infection with WT LM by secreting IFN- . 3   106 nylon wool-purified
OT-I splenocytes were transferred into B6.Thy1.1 hosts. The mice were
then challenged with 2   106 PFU VSV/OVA and rested for  4 wk to
generate stable memory populations of OT-I T cells. The mice were re-
challenged with varying doses of WT LM. 16 h after infection, the mice
were killed and the splenocytes were cultured for 3 h in RPMI media
containing GolgiPlug™ (no cytokines or antigens were added). The cells
were subsequently harvested and stained for CD8, Thy1.2, and intracellular
IFN- . The results shown are the average of two mice. Similar results
were obtained using B6.Thy1.1 mice that were OT-I transferred, primed
with VV/OVA, rested for  4 wk and rechallenged with WT LM.T
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OT-I T cells did not affect the gene expression of the IL-
12 and IL-18 receptors. In addition, we observed that
memory OT-I T cells generated by priming with either
VV/OVA or VSV/OVA expressed high levels of the IL-
18R  subunit, explaining their increased responsiveness to
IL-12 and IL-18 (unpublished data).
Differences in LM Susceptibility Between B6 and IFN-  / 
Mice. To investigate the early kinetics of the innate re-
quirements for IFN-  during an LM infection, we com-
pared the susceptibility of B6 and IFN-  /  mice infected
with  104 LM on days 1, 2, and 3 postinfection. The dif-
ferences in LM susceptibility, as determined by LM counts
in the spleen and liver, are only detectable between 2–3 d
postinfection (Fig. 7). These data indicate that IFN-  is im-
portant during the innate immune response to LM, but the
importance of this effector cytokine does not manifest itself
immediately after infection.
Early Protection of IFN-  /  Mice from LM Infection by
Memory CD8  T Cells Independent of Antigen Specificity.
Our data suggest that antigen nonspecific secretion of IFN- 
in response to WT LM by memory CD8  T cells may
play a role in protective immunity against LM and that this
response can be visualized within 16 h (Fig. 5). Further-
more, differences in LM counts mediated by IFN-  can
only be seen 2–3 d postinfection (Fig. 7). Therefore, we
transferred memory OT-I T cells into IFN-  /  mice in-
fected with  104 LM and determined spleen and liver LM
counts 3 d postinfection. Spleen and liver LM counts for
IFN-  /  mice on day 3 after infection show high numbers
of bacterial colonies compared with WT B6 control ani-
mals, as expected (Fig. 8 A). In contrast, IFN-  /  mice
that received 5   105 sorted memory OT-I T cells before
LM infection show  2 logs of protection in both organs.
We were able to detect CFSE staining of the transferred
memory OT-I T cells 3 d postinfection (Fig. 8 B). As few as
 5,000 IFN- –secreting OT-I T cells are able to reduce
the LM counts in IFN-  /  mice almost to the levels of a
B6 mouse. The small number of OT-I T cells recovered 3 d
postinfection is most likely attributed to loss upon injection,
localization to other organs, and the fact that not all of the
OT-I T cells secrete IFN-  at the time of the assay. Impor-
tantly, there are  290-fold fewer IFN- –secreting cells in
the IFN-  /  mice transferred with memory OT-I T cells
compared with the B6 mice (Fig. 8 C). It should be noted
that this response does not represent cross-reactivity be-
tween the SIINFEKL epitope and LM since the transferred
cells show no evidence of dilution of the CFSE label (Fig. 8
B). Our previous data indicate that naive OT-I T cells are
not responsive to IL-12 and IL-18 and that they do not ex-
press high levels of the receptors for these cytokines (Figs. 2
and 6). In accordance with this data, when we transferred
naive OT-I T cells into IFN-  /  mice they were unable
to protect these animals from a WT LM infection (Fig. 8
D). These results are also demonstrated in an independent
experiment where we transferred naive or memory OT-I T
cells into IFN- –deficient mice and challenged both sets of
Figure 6. Effector and memory OT-I T cells up-regulate IL-12R 2,
IL-18R , and IL-18R . (A) Naive, effector, and memory OT-I T cells
were purified as described in Materials and Methods. mRNA was then
purified, cDNA generated, and real-time RT-PCR performed. The results
were normalized to GAPDH levels to control for quantity of cDNA in
each sample. The levels of each of the receptors was set to a value of one
for the naive OT-I population, and the results are presented as fold increase
of mRNA over the naive OT-I population. Each reaction was performed
in triplicate, and the data are the average of the triplicate. Levels of the
IL-18R  subunit were measured on populations of naive OT-I T cells
(B), effector OT-I T cells (C), and memory OT-I T cells (D). For the naive
population, V 2 , CD8  splenocytes from naive OT-I mice were gated
on for the analysis of the IL-18R  subunit. For the effector population,
nylon wool-purified OT-I splenocytes were transferred into B6.Thy1.1
hosts, which were then challenged with  2,000 LM/OVA. 7 d postin-
fection, splenocytes were stained, and the CD8 , Thy1.2  population of
OT-I T cells was gated on for analysis of the IL-18R  subunit. The
memory population was generated in the same manner as the effector
population, except the mice were rested for  4 wk before analysis. The
open histograms represent background staining in the absence of the primary
antibody, whereas the filled histograms represent staining in the presence
of the primary antibody. Each histogram is staining from one representative
of four mice.
Figure 7. Innate susceptibility of B6 and IFN-     mice to LM infection.
B6 and IFN-  /  mice were infected with  104 LM. At days 1, 2, and 3
postinfection, the mice were killed and spleen (A) and liver (B) LM
counts were determined by plating 10-fold dilutions of the homogenized
organs on BHI plates. Three mice per group were averaged for days 1 and
2, whereas eight mice per group were averaged for day 3. Similar results
were obtained in independent experiments performed on days 1, 2, and 4
postinfection.T
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mice with 104 WT LM (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20031051/DC1).
Discussion
CD8  T cells play an important role in the control and
elimination of LM and other intracellular pathogens. Signals
propagated through the TCR upon binding to peptide–
MHC complexes can induce a myriad of effects including
proliferation, cytokine secretion, cytolysis of infected tar-
gets, and apoptosis of the T cells themselves (44). Genera-
tion of memory CD8  T cells results in rapid responses
upon reexposure to the same pathogen. In addition, mem-
ory CD8  T cells have been shown to preferentially localize
to peripheral nonlymphoid organs (41, 43). Recent reports
in both human and murine systems have suggested that
memory CD8  T cells may belong to distinct subsets,
termed central and effector, based upon their existence in
either lymphoid or nonlymphoid organs (45, 46). Central
memory CD8  T cells are CD62Lhi and CCR7  allowing
homing to LNs, whereas effector memory CD8  T cells are
CD62Llo and CCR7  and do not have this homing prop-
erty. Effector memory CD8  T cells have been proposed to
respond rapidly to a secondary infection by performing ef-
fector functions (46), although this has been questioned re-
cently (45). Data presented here indicate that memory
CD8  T cells can respond rapidly in an antigen nonspecific
manner by secreting IFN-  (Figs. 2 and 5). We have iso-
lated these memory CD8  T cells from both lymphoid and
nonlymphoid organs (Fig. 4). Therefore, they may belong
to either subset of memory CD8  T cells. Furthermore, we
have shown previously that both CD62Lhi and CD62Llo
CD8  T cells have the capacity to secrete IFN-  upon ex-
posure to IL-12 and IL-18 (36). Importantly, the localiza-
tion of memory CD8  T cells to sites of infection such as
the GI tract, lung, and liver make our findings relevant in
terms of an immediate response against an infection.
IFN-  is critical in immune responses against certain
pathogens. For example, the published LD50 of IFN- –
deficient Balb/c mice in response to LM is  10 (31). How-
ever, LM-specific CD8  T cells generated in these mice
can provide protective immunity to future LM infections.
In addition, studies using SCID mice lacking T and B lym-
phocytes have demonstrated increased LM burdens upon
depletion of IFN-  (33). These results suggest that IFN- 
is required during the innate immune response to LM. In-
deed, our data indicate that IFN- –deficient mice are
highly susceptible to LM infections but that the differences
in LM burden between B6 and IFN-  /  mice are not ap-
parent until 2–3 d postinfection (Fig. 7). Although IFN- 
can have direct effects on LM growth by limiting escape
from the phagosome (47), the major role of this cytokine
may be in inducing macrophage activity or polarizing to-
ward a Th1-type immune response (2). Exactly what role
the IFN-  that is secreted rapidly from antigen nonspecific
memory CD8  T cells plays was not determined in our
studies. However, it is involved in controlling the early,
rapid growth of LM that would otherwise occur in IFN- –
deficient mice (Fig. 8).
Our experiments have used three different pathogens, all
expressing the OVA protein, to induce effector and memory
CD8  T cells. In each case, the CD8  T cells acquired the
ability to secrete IFN-  in response to IL-12 and IL-18 and
up-regulated the expression of the IL-12 and IL-18 receptors
(Fig. 6). Whether or not IL-12 and IL-18 production during
Figure 8. Memory OT-I T cells protect IFN-     mice from a WT
LM infection. 3   106 nylon wool-purified OT-I splenocytes were trans-
ferred into B6.Thy1.1 mice and then challenged with 2   106 PFU VV/
OVA. The mice were then rested for  4 wk, killed, and the splenocytes
were sorted for CD8 , Thy1.2  OT-I T cells. 5   105 CFSE labeled
memory OT-I T cells were injected into IFN-  /  recipients. (A) B6,
IFN-  / , and IFN-  /  mice transferred with memory OT-I T cells
were then infected with  104 WT LM and killed 3 d later to determine
spleen and liver LM counts. (B and C) Splenocytes from the above mice
were cultured for 3 h in media containing GolgiPlug™ and then analyzed
for CFSE, CD8, and intracellular IFN-  expression. The number of
IFN- –secreting OT-I T cells was calculated by multiplying the total
number of splenocytes isolated from the infected mice by the percentage
of CFSE-labeled, CD8 , IFN-   cells determined by flow cytometry.
The number of IFN- –secreting cells in the B6 mice was calculated by
multiplying the total number of splenocytes isolated from the infected
mice by the percentage of IFN- –secreting cells determined by flow cy-
tometry. (D) Naive OT-I T cells were sorted for CD8 , V 2 , and
CD44lo expression. 5   105 CFSE-labeled naive OT-I T cells were in-
jected into IFN-  /  recipients. B6, IFN-  / , and IFN-  /  mice
transferred with naive OT-I T cells were then infected with  104 WT
LM and killed 3 d later to determine spleen and liver LM counts. The
data shown are the average of three mice per group for A–C and two
mice per group for D. Each experiment is one representative of two.T
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the priming phase of CD8  T cell activation is required for
the increase in expression of the receptors for the cytokines is
unclear. Signaling through the TCR upon binding to the
cognate peptide–MHC complex may result in up-regulation
of the IL-12 and IL-18 receptors in CD8  T cells. It is likely
that for each of the pathogens used the OVA antigen (SIIN-
FEKL) is actually presented by DC through cross-priming
(48). Recent work suggests that CD8  DC are responsible
for cross-priming CD8  T cells and that this subset of DC
produce high amounts of IL-12 (49, 50). DC of different
types are also capable of secreting IL-18 (51). Therefore, it
seems likely that IL-12 and IL-18 may be produced during
the priming phase required to induce responsiveness of the
CD8  T cells to IL-12 and IL-18.
It is interesting to note that IL-12 and IL-18 did not in-
duce any other effector functions, including proliferation,
cytotoxicity, or secretion of TNF-  from effector or mem-
ory CD8  T cells (unpublished data). Recent studies have
demonstrated that IL-12 can have other effects on T cells,
such as inducing the indirect proliferation of memory CD8 
T cells (52). IL-12 has also been shown to be necessary for
complete activation of naive CD8  T cells but not memory
CD8  T cells (53). IL-18 has been implicated in up-regulat-
ing the cytotoxic activities of CD8  T cells (23). Our results
indicate that the secretion of cytokine-induced IFN-  by
CD8  T cells is under exquisite control. Once IL-12 and
IL-18 are no longer produced, which should be rapid under
conditions of a controllable infection, then IFN-  will cease
to be secreted from effector and memory CD8  T cells.
The most striking result of this study is that so few mem-
ory CD8  T cells can protect IFN- –deficient mice 3 d
post LM infection (Fig. 8). Considering other cell types can
respond rapidly to LM by secreting IFN- , there may be
redundancy in this early response. Alternatively, the extra
IFN-  production resulting from multiple cell types may
be required in order to establish a Th1 environment, aiding
in the generation and effectiveness of the adaptive immune
response. The ability of NK, NK-T, and    T cells to pro-
vide innate immune protection is a possibility that is being
considered. In conclusion, the results presented here dem-
onstrate that IFN-  production from antigen nonspecific
memory CD8  T cells is sufficient in providing innate im-
mune protection against LM. Furthermore, this study high-
lights the fact that CD8  T cells can function in settings
other than the adaptive immune response.
We would like to thank Angie Mobley in the Dallas Cell Analysis
Facility for cell sorting and Charles Nguyen for assistance with the
real-time RT-PCR.
This work was supported by National Institutes of Health grants
AI37818 and AI45764 to J. Forman and a National Institutes of
Health Postdoctoral Fellowship to R. Berg.
Submitted: 26 June 2003
Accepted: 6 October 2003
References
1. Portnoy, D.A. 1992. Innate immunity to a facultative intra-
cellular bacterial pathogen. Curr. Opin. Immunol. 4:20–24.
2. Unanue, E.R. 1997. Studies in listeriosis show the strong
symbiosis between the innate cellular system and the T-cell
response. Immunol. Rev. 158:11–25.
3. Mombaerts, P., J. Arnoldi, F. Russ, S. Tonegawa, and S.H.
Kaufmann. 1993. Different roles of alpha beta and gamma
delta T cells in immunity against an intracellular bacterial
pathogen. Nature. 365:53–56.
4. MacMicking, J.D., C. Nathan, G. Hom, N. Chartrain, D.S.
Fletcher, M. Trumbauer, K. Stevens, Q.W. Xie, K. Sokol,
N. Hutchinson, et al. 1995. Altered responses to bacterial-
infection and endotoxic-shock in mice lacking inducible ni-
tric-oxide synthase. Cell. 81:641–650.
5. Beckerman, K.P., H.W. Rogers, J.A. Corbett, R.D.
Schreiber, M.L. McDaniel, and E.R. Unanue. 1993. Release
of nitric oxide during the T cell-independent pathway of
macrophage activation. Its role in resistance to Listeria monocy-
togenes. J. Immunol. 150:888–895.
6. Dinauer, M.C., M.B. Deck, and E.R. Unanue. 1997. Mice
lacking reduced nicotinamide adenine dinucleotide phos-
phate oxidase activity show increased susceptibility to early
infection with Listeria monocytogenes. J. Immunol. 158:5581–
5583.
7. Endres, R., A. Luz, H. Schulze, H. Neubauer, A. Futterer,
S.M. Holland, H. Wagner, and K. Pfeffer. 1997. Listeriosis in
p47(phox / ) and TRp55 /  mice: protection despite
absence of ROI and susceptibility despite presence of RNI.
Immunity. 7:419–432.
8. Shiloh, M.U., J.D. MacMicking, S. Nicholson, J.E. Brause,
S. Potter, M. Marino, F. Fang, M. Dinauer, and C. Nathan.
1999. Phenotype of mice and macrophages deficient in both
phagocyte oxidase and inducible nitric oxide synthase. Immu-
nity. 10:29–38.
9. Fehr, T., G. Schoedon, B. Odermatt, T. Holtschke, M.
Schneemann, M.F. Bachmann, T.W. Mak, I. Horak, and
R.M. Zinkernagel. 1997. Crucial role of interferon consen-
sus sequence binding protein, but neither of interferon regu-
latory factor 1 nor of nitric oxide synthesis for protection
against murine listeriosis. J. Exp. Med. 185:921–931.
10. Rosen, H., S. Gordon, and R.J. North. 1989. Exacerbation
of murine listeriosis by a monoclonal antibody specific for the
type-3 complement receptor of myelomonocytic cells—absence
of monocytes at infective foci allows Listeria to multiply in
nonphagocytic cells. J. Exp. Med. 170:27–37.
11. Conlan, J.W., and R.J. North. 1994. Neutrophils are essen-
tial for early anti-Listeria defense in the liver, but not in the
spleen or peritoneal cavity, as revealed by a granulocyte-
depleting monoclonal antibody. J. Exp. Med. 179:259–268.
12. Havell, E.A., L.L. Moldawer, D. Helfgott, P.L. Kilian, and
P.B. Sehgal. 1992. Type-I Il-1 receptor blockade exacerbates
murine listeriosis. J. Immunol. 148:1486–1492.
13. Rogers, H.W., C.S. Tripp, R.D. Schreiber, and E.R.
Unanue. 1994. Endogenous Il-1 Is Required for neutrophil
recruitment and macrophage activation during murine listeri-
osis. J. Immunol. 153:2093–2101.
14. Havell, E.A., and P.B. Sehgal. 1991. Tumor necrosis factor-
independent Il-6 production during murine listeriosis. J. Im-
munol. 146:756–761.
15. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lam-
ers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G.
Kohler. 1994. Impaired immune and acute-phase responses
in interleukin-6-deficient mice. Nature. 368:339–342.
16. Dalrymple, S.A., L.A. Lucian, R. Slattery, T. Mcneil, D.M.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
Innate Immunity Mediated by CD8  T Cells 1592
Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-
6-deficient mice are highly susceptible to Listeria-monocytoge-
nes infection—correlation with inefficient neutrophilia. Infect.
Immun. 63:2262–2268.
17. Ehlers, S., C. Holscher, S. Scheu, C. Tertilt, T. Hehlgans, J.
Suwinski, R. Endres, and K. Pfeffer. 2003. The lymphotoxin
beta receptor is critically involved in controlling infections
with the intracellular pathogens Mycobacterium tuberculosis and
Listeria monocytogenes. J. Immunol. 170:5210–5218.
18. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kol-
lias. 1996. Immune and inflammatory responses in TNF al-
pha-deficient mice: a critical requirement for TNF alpha in
the formation of primary B cell follicles, follicular dendritic
cell networks and germinal centers, and in the maturation of
the humoral immune response. J. Exp. Med. 184:1397–1411.
19. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F.
Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H.
Bluethmann. 1993. Mice lacking the tumour necrosis factor
receptor 1 are resistant to TNF-mediated toxicity but highly
susceptible to infection by Listeria monocytogenes. Nature. 364:
798–802.
20. Tripp, C.S., S.F. Wolf, and E.R. Unanue. 1993. Interleukin
12 and tumor necrosis factor alpha are costimulators of inter-
feron gamma production by natural killer cells in severe com-
bined immunodeficiency mice with listeriosis, and interleu-
kin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA.
90:3725–3729.
21. Tripp, C.S., M.K. Gately, J. Hakimi, P. Ling, and E.R.
Unanue. 1994. Neutralization of IL-12 decreases resistance to
Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.
J. Immunol. 152:1883–1887.
22. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A.
Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada,
and K. Hattori. 1995. Cloning of a new cytokine that induces
IFN-gamma production by T cells. Nature. 378:88–91.
23. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura.
2001. Interleukin-18 is a unique cytokine that stimulates
both Th1 and Th2 responses depending on its cytokine mi-
lieu. Cytokine Growth Factor Rev. 12:53–72.
24. Neighbors, M., X. Xu, F.J. Barrat, S.R. Ruuls, T. Chura-
kova, R. Debets, J.F. Bazan, R.A. Kastelein, J.S. Abrams, and
A. O’Garra. 2001. A critical role for interleukin 18 in pri-
mary and memory effector responses to Listeria monocytogenes
that extends beyond its effects on interferon gamma produc-
tion. J. Exp. Med. 194:343–354.
25. Bancroft, G.J. 1993. The role of natural killer cells in innate
resistance to infection. Curr. Opin. Immunol. 5:503–510.
26. Leite-De-Moraes, M.C., A. Hameg, A. Arnould, F.
Machavoine, Y. Koezuka, E. Schneider, A. Herbelin, and M.
Dy. 1999. A distinct IL-18-induced pathway to fully activate
NK T lymphocytes independently from TCR engagement. J.
Immunol. 163:5871–5876.
27. Munder, M., M. Mallo, K. Eichmann, and M. Modolell.
1998. Murine macrophages secrete interferon gamma upon
combined stimulation with interleukin (IL)-12 and IL-18: a
novel pathway of autocrine macrophage activation. J. Exp.
Med. 187:2103–2108.
28. Ganapamo, F., V.A. Dennis, and M.T. Philipp. 2001.
CD19( ) cells produce IFN-gamma in mice infected with
Borrelia burgdorferi. Eur. J. Immunol. 31:3460–3468.
29. Stober, D., R. Schirmbeck, and J. Reimann. 2001. IL-12/IL-
18-dependent IFN-gamma release by murine dendritic cells.
J. Immunol. 167:957–965.
30. Ferrick, D.A., M.D. Schrenzel, T. Mulvania, B. Hsieh, W.G.
Ferlin, and H. Lepper. 1995. Differential production of inter-
feron-gamma and interleukin-4 in response to Th1-stimulat-
ing and Th2-stimulating pathogens by gamma-delta T-cells
in-vivo. Nature. 373:255–257.
31. Harty, J.T., and M.J. Bevan. 1995. Specific immunity to List-
eria monocytogenes in the absence of IFN gamma. Immunity.
3:109–117.
32. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Blueth-
mann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M.
Aguet. 1993. Immune response in mice that lack the inter-
feron-gamma receptor. Science. 259:1742–1745.
33. Bancroft, G.J., R.D. Schreiber, G.C. Bosma, M.J. Bosma,
and E.R. Unanue. 1987. A T cell-independent mechanism
of macrophage activation by interferon-gamma. J. Immunol.
139:1104–1107.
34. Dai, W.J., W. Bartens, G. Kohler, M. Hufnagel, M. Kopf,
and F. Brombacher. 1997. Impaired macrophage listericidal
and cytokine activities are responsible for the rapid death of
Listeria monocytogenes-infected IFN-gamma receptor-deficient
mice. J. Immunol. 158:5297–5304.
35. Teixeira, H.C., and S.H.E. Kaufmann. 1994. Role of
Nk1.1( ) cells in experimental listeriosis—Nk1( ) cells are
early Ifn-gamma producers but impair resistance to Listeria-
monocytogenes infection. J. Immunol. 152:1873–1882.
36. Berg, R.E., C.J. Cordes, and J. Forman. 2002. Contribution
of CD8  T cells to innate immunity: IFN-gamma secretion
induced by IL-12 and IL-18. Eur. J. Immunol. 32:2807–2816.
37. Lertmemongkolchai, G., G. Cai, C.A. Hunter, and G.J. Ban-
croft. 2001. Bystander activation of CD8  T cells contrib-
utes to the rapid production of IFN-gamma in response to
bacterial pathogens. J. Immunol. 166:1097–1105.
38. Pope, C., S.K. Kim, A. Marzo, D. Masopust, K. Williams, J.
Jiang, H. Shen, and L. Lefrancois. 2001. Organ-specific regu-
lation of the CD8 T cell response to Listeria monocytogenes in-
fection. J. Immunol. 166:3402–3409.
39. Kim, S.K., D.S. Reed, S. Olson, M.J. Schnell, J.K. Rose,
P.A. Morton, and L. Lefrancois. 1998. Generation of mu-
cosal cytotoxic T cells against soluble protein by tissue-spe-
cific environmental and costimulatory signals. Proc. Natl.
Acad. Sci. USA. 95:10814–10819.
40. Restifo, N.P., I. Bacik, K.R. Irvine, J.W. Yewdell, B.J. Mc-
Cabe, R.W. Anderson, L.C. Eisenlohr, S.A. Rosenberg, and
J.R. Bennink. 1995. Antigen processing in vivo and the elic-
itation of primary CTL responses. J. Immunol. 154:4414–
4422.
41. Masopust, D., V. Vezys, A.L. Marzo, and L. Lefrancois.
2001. Preferential localization of effector memory cells in
nonlymphoid tissue. Science. 291:2413–2417.
42. Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative
gene expression data using real-time quantitative PCR and
the 2(T)(-Delta Delta C) method. Methods. 25:402–408.
43. Marshall, D.R., S.J. Turner, G.T. Belz, S. Wingo, S. An-
dreansky, M.Y. Sangster, J.M. Riberdy, T.B. Liu, M. Tan,
and P.C. Doherty. 2001. Measuring the diaspora for virus-
specific CD8( ) T cells. Proc. Natl. Acad. Sci. USA. 98:
6313–6318.
44. Harty, J.T., A.R. Tvinnereim, and D.W. White. 2000.
CD8( ) T cell effector mechanisms in resistance to infec-
tion. Annu. Rev. Immunol. 18:275–308.
45. Wherry, E.J., V. Teichgraber, T.C. Becker, D. Masopust,
S.M. Kaech, R. Antia, U.H. von Andrian, and R. Ahmed.
2003. Lineage relationship and protective immunity of mem-T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
Berg et al. 1593
ory CD8 T cell subsets. Nat. Immunol. 4:225–234.
46. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavec-
chia. 1999. Two subsets of memory T lymphocytes with dis-
tinct homing potentials and effector functions. Nature. 401:
708–712.
47. Portnoy, D.A., R.D. Schreiber, P. Connelly, and L.G. Tilney.
1989. Gamma-interferon limits access of Listeria monocytogenes
to the macrophage cytoplasm. J. Exp. Med. 170:2141–2146.
48. Heath, W.R., and F.R. Carbone. 2001. Cross-presentation,
dendrttic cells, tolerance and immunity. Annu. Rev. Immunol.
19:47–64.
49. den Haan, J.M.M., S.M. Lehar, and M.J. Bevan. 2000.
CD8( ) but not CD8( ) dendritic cells cross-prime cyto-
toxic T cells in vivo. J. Exp. Med. 192:1685–1695.
50. Maldonado-Lopez, R., T. De Smedt, P. Michel, J. Godfroid,
B. Pajak, C. Heirman, K. Thielemans, O. Leo, J. Urbain, and
M. Moser. 1999. CD8 alpha( ) and CD8 alpha( ) sub-
classes of dendritic cells direct the development of distinct T
helper cells in vivo. J. Exp. Med. 189:587–592.
51. Stoll, S., H. Jonuleit, E. Schmitt, G. Muller, H. Yamauchi,
M. Kurimoto, J. Knop, and A.H. Enk. 1998. Production of
functional IL-18 by different subtypes of murine and human
dendritic cells (DC): DC-derived IL-18 enhances IL-12-depen-
dent Th1 development. Eur. J. Immunol. 28:3231–3239.
52. Tough, D.F., X. Zhang, and J. Sprent. 2001. An IFN-
gamma-dependent pathway controls stimulation of memory
phenotype CD8  T cell turnover in vivo by IL-12, IL-18,
and IFN-gamma. J. Immunol. 166:6007–6011.
53. Curtsinger, J.M., D.C. Lins, and M.F. Mescher. 2003. Signal
3 determines tolerance versus full activation of naive CD8 T
cells: dissociating proliferation and development of effector
function. J. Exp. Med. 197:1141–1151.